In one paragraphArticle in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Sarah Flora JonasBiostatistics and Epidemiology Office, Gustave Roussy, INSERM U1018 Oncostat, Labelled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France.ORCID 0000-0002-4346-1806 Fabian KnoerrPediatric Hematology and Oncology and NHL-BFM Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-1831-3702 Anne AuperinBiostatistics and Epidemiology Office, Gustave Roussy, INSERM U1018 Oncostat, Labelled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France.ORCID 0000-0003-1545-0373 Sarah AlexanderDivision of Hematology/Oncology/Bone Marrow Transplantation, BC Children's Hospital, The University of British Columbia, Vancouver, Canada.ORCID 0000-0002-9695-1702 Mara AndresDepartment of Pediatric Hematology and Oncology, University Hospital La Fe of Valencia, Valencia, Spain.
Andishe AttarbaschiDepartment of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-9285-6898 G A Amos BurkeCancer Research UK Clinical Trials Unit, School of Medical Sciences, The University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0003-2671-9972 Birgit BurkhardtDepartment of Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany.ORCID 0000-0002-1151-829X Francesco CeppiPediatric Hematology-Oncology Unit, Division of Pediatrics, Department of Woman-Mother-Child, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland.
Thomas GrossDepartment of Pediatric Hematology and Oncology, Phoenix Children's Hospital, Phoenix, AZ.
Edita KabickovaDepartment of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
Rodney R MilesDepartment of Pathology, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.
Martin ZimmermannDepartment of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany.
Veronique Minard-ColinDepartments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.ORCID 0000-0002-0296-5207 Wilhelm WoessmannPediatric Hematology and Oncology and NHL-BFM Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID41979343
PMCPMC13276538
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390